Home

Home

article image

The Acuson P10 portable ultrasound device.

Acuson P10 – the world’s smallest ultrasound device

The Acuson P10 is a new portable ultrasound device, developed and manufactured by Siemens Medical Solutions. The new system in the size of a Blackberry embodies Point of Care Testing (POCT) abilities: It weighs a little more than 700 grams and could be used for earliest possible diagnostics in an intensive care unit, ambulance or medical helicopter, providing physicians with valuable information about their patients’ condition.

The Acuson P10 system is the world's smallest ultrasound device. It is equipped with a touch-screen LCD display that measures 3.7 inches diagonally, allowing easy menu-navigation similar to a Personal Digital Assistant (PDA). Designed for diagnostic use in emergency medicine, cardiology and obestetrics, a lithium ion battery enables approximately one hour of continuous scanning.
“Instead of having to rush the patient to the technology, P10 brings the technology to the patient, which can reduce critical minutes, particularly when a patient is in cardiac distress or with trauma patients, who have multiple injuries,” explains Klaus Hambuechen, head of the Ultrasound Division of Siemens Medical Solutions.

The Acuson P10’s emergency applications include FAST (Focused Abdominal Sonography for Trauma) for detecting fluid, determining cardiac activity and pericardial effusion as well as for detecting abdominal aortic aneurysms and performing pelvic exams.
The device can also determine fetal viability, fetal positioning, amniotic fluid volume, bleeding and miscarriage.
“The flexibility and portability of the P10 mark significant changes in the way diagnostic and emergency care are administered, changes that could alter the face of the physical exam and, ultimately, lead to better patient outcomes,” concludes Klaus Hambuechen.

This article was published on 09/19/2007

Search

 

Service

Company News

Insulin in oral capsules

At the international congress on diabetes in September, Oramed Pharmaceuticals, Inc. introduced its oral insulin capsules that might in the future replace injections patients currently have to face. Last week Oramed announced the agreement with ETI Karle Clinical Pvt. Ltd. to conduct phase 2B clinical trials for its oral insulin capsules.

Products redesigned to help patients simplify life with diabetes

Bayer HealthCare Diabetes Care unveiled the new
CONTOUR® blood glucose meter with enhanced testing features at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome, Italy.

Carestream: technical infrastructure for EU funded R-bay project

Carestream Health is a major technical infrastructure provider to the EU-funded R-Bay validation project, which aims to address the uneven spread of radiologists across member states. CARESTREAM Radiology and Information Management Solutions are driving the initial test platform for the project by facilitating remote reporting of images from hospitals in Denmark, Finland and Czech Republic by clinical providers in Estonia, Lithuania and the Netherlands.